BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Prognosis
1804 results:

  • 1. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
    Güzel D; Terek C; Besler A; Serin G; Önal Z; Akman L; Göker E; Ali Şanli U; Zekioğlu O; Özdemir N; Özsaran A; Yildirim N
    Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():321-326. PubMed ID: 38518487
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of prognostic factors and construction of nomogram to predict cancer-specific survival for patients with ovarian granulosa cell tumors.
    Zhang Y; Zhang Z; Ding X; Zhang K; Dai Y; Cheng W; Luo C
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2046. PubMed ID: 38507268
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DNA Methylation of a Group of Long Non-Coding RNA Genes at Different Stages of ovarian cancer Dissemination.
    Burdennyy AM; Filippova EA; Lukina SS; Ivanova NA; Pronina IV; Loginov VI; Kazubskaya TP; Kushlinskii NE; Braga EA
    Bull Exp Biol Med; 2024 Feb; 176(4):495-500. PubMed ID: 38492100
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.
    Feng S; Ding B; Dai Z; Yin H; Ding Y; Liu S; Zhang K; Lin H; Xiao Z; Shen Y
    J Transl Med; 2024 Mar; 22(1):280. PubMed ID: 38491511
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon.
    Yaacoub S; Hajj L; Khairallah A
    BMC Cancer; 2024 Mar; 24(1):309. PubMed ID: 38448917
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Review on Sertoli-Leydig Cell Tumours of the Ovary.
    Muscat C; Calleja-Agius J
    Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive machine learning-based preoperative blood features predict the prognosis for ovarian cancer.
    Wu M; Gu S; Yang J; Zhao Y; Sheng J; Cheng S; Xu S; Wu Y; Ma M; Luo X; Zhang H; Wang Y; Zhao A
    BMC Cancer; 2024 Feb; 24(1):267. PubMed ID: 38408960
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health.
    De Matteis E; Tumolo MR; Tarantino P; Ciccarese M; Grassi T; Bagordo F; De Giorgio MR; Rizzo E; Ronzino G
    Oncotarget; 2024 Feb; 15():134-141. PubMed ID: 38386807
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
    Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
    Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. prognosis of uterine and extrauterine low-grade endometrial stromal sarcoma: an observational cohort study.
    Dai Q; Xu B; Wu H; You Y; Li L
    Int J Surg; 2024 Apr; 110(4):1919-1928. PubMed ID: 38329091
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A 19-Gene Signature of Serous ovarian cancer Identified by Machine Learning and Systems Biology: Prospects for Diagnostics and Personalized Medicine.
    Kori M; Demirtas TY; Comertpay B; Arga KY; Sinha R; Gov E
    OMICS; 2024 Feb; 28(2):90-101. PubMed ID: 38320250
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
    Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L
    World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Proteomic insight towards key modulating proteins regulated by the aryl hydrocarbon receptor involved in ovarian carcinogenesis and chemoresistance.
    Therachiyil L; Peerapen P; Younis SM; Ahmad A; Thongboonkerd V; Uddin S; Korashy HM
    J Proteomics; 2024 Mar; 295():105108. PubMed ID: 38316181
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Therapeutic management of uterine tumours resembling ovarian sex cord tumours including a focus on fertility: A systematic review.
    Shibahara M; Kurita T; Harada H; Tsuda Y; Hisaoka M; Yoshino K
    Eur J Obstet Gynecol Reprod Biol; 2024 Apr; 295():1-7. PubMed ID: 38310674
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Low-grade endometrioid endometrial cancer with adnexal only metastasis: Evaluation of de-escalation of adjuvant therapy.
    Matsuo K; Chen L; Neuman MK; Klar M; Roman LD; Wright JD
    Eur J Cancer; 2024 Mar; 200():113533. PubMed ID: 38309016
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites.
    Kim Y; Ajiki T; Ueda Y; Yoshida Y; Takahashi T; Fukuyama H; Fukuyama T; Hori Y
    Anticancer Res; 2024 Feb; 44(2):613-619. PubMed ID: 38307557
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Distribution and prognostic role of BRCA status in elderly ovarian cancer patients.
    Tortorella L; Cappuccio S; Giannarelli D; Nero C; Marchetti C; Gallotta V; Costantini B; Pasciuto T; Minucci A; Fagotti A; Scambia G
    Gynecol Oncol; 2024 Mar; 182():57-62. PubMed ID: 38262239
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord-stromal tumors. Results of the TGM13 National Registry.
    Fuentes C; Ouldbey Y; Orbach D; Sudour-Bonnange H; Verité C; Rome A; Dumesnil C; Thebaud E; Hameury F; Dijoud F; Chabaud S; Cote MD; Fresneau B; Faure-Conter C
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30864. PubMed ID: 38259036
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CX3CR1 is a potential biomarker of immune microenvironment and prognosis in epithelial ovarian cancer.
    Shao D; Zhou H; Yu H; Zhu X
    Medicine (Baltimore); 2024 Jan; 103(3):e36891. PubMed ID: 38241595
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 91.